NCT06078930Recruiting
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
A Multi-center Observational Clinical Study on the Development of Artificial Intelligence-Based Gastric Cancer Screening and Diagnosis Technology Using Multi-Omics Analysis of Tongue Imaging and Tongue Coating
Source: ClinicalTrials.gov · Last updated 4 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In this study, the investigators will prospectively recruit 100,000 individuals, including gastric cancer patients who have not undergone any anti-tumor treatment and non-gastric cancer participants. The investigators will construct a diagnostic model for malignant tumors based on the combination of tongue imaging, tongue coating, saliva, gastric juice, and fecal multi-omics data (including metagenomics, proteomics, metabolomics, etc.). Additionally, the study will explore the relationship between oral, gastric, and intestinal microbiota and the development of malignant tumors.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100000 (estimated)
- First submitted
- 5 Oct 2023
- Start date
- 1 Jun 2021
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- Zhejiang Cancer Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06078930
What you commit to
- Study type: Observational
- Planned participants: 100000
- From 1 Jun 2021 to the primary completion date, 1 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Two or more kinds of malignant tumors at the same time
- Gastric cancer that has been treated by chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor therapy
- History of long-term medication
- Presence of oral diseases such as tooth and gum diseases
- History of malignant tumors
- History of long-term medication
- Presence of oral diseases such as tooth and gum diseases
Lab values
- Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers
- Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers
Other
- The use of glucocorticoids and antibiotics in the past three months
- The use of glucocorticoids and antibiotics in the past three months
Who the study is looking for
- 18≤age≤90
- Histologically or cytologically confirmed gastric cancer
- No prior chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor treatment for gastric cancer
- Subject volunteers to join the study, Signs informed consent, has good compliance and can cooperate with follow-up
- 18≤age≤90
- Willingness to participate in the study, signing an informed consent form, and demonstrating good compliance
Age in the registry: 18 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhejiang Cancer Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.